comscoreDoes Immunotherapy Before Breast Cancer Surgery Offer Benefits? — Heard in the Halls: 2019 SABCS

Does Immunotherapy Before Breast Cancer Surgery Offer Benefits? — Heard in the Halls: 2019 SABCS

Dr. Luca Gianni discusses the results of the NeoTRIP trial.
Jan 8, 2020
00:00
Download
00:00

Dr. Gianni discusses the results of the NeoTRIP trial, which looked to see if adding the immunotherapy medicine Tecentriq (chemical name: atezolizumab) to chemotherapy before surgery for triple-negative breast cancer with a high risk of recurrence could improve the time women lived without the cancer coming back.

About the guest
 
Luca Gianni, MD

Dr. Luca Gianni is president of the Fondazione Michelangelo in Milan, Italy.

— Last updated on May 5, 2022, 7:09 PM

 
 
Support Breastcancer.org to produce more content like this

Your donation goes directly to what you read, hear, and see on Breastcancer.org.

Donate